The American journal of gastroenterology
Cost-effectiveness of first-line regimens for Helicobacter pylori infection in the United States.
Ligang Liu, Kang Wang, Marjorie V Neidecker, Haoran Yang, Nahata C Milap
Published: 202610.14309/ajg.0000000000003924
Abstract
INTRODUCTION: Helicobacter pylori (H. pylori) infection remains a significant global health burden. The 2024 American College of Gastroenterology (ACG) guideline recommended bismuth quadruple therapy (BQT) as the first-line treatment for treatment-na…
Preview only. Read the full abstract at the source